Literature DB >> 28797850

Advance Care Planning in Palliative Care for People With Intellectual Disabilities: A Systematic Review.

Hille Voss1, Anique Vogel2, Annemieke M A Wagemans2, Anneke L Francke3, Job F M Metsemakers4, Annemie M Courtens5, Anke J E de Veer6.   

Abstract

CONTEXT: Advance care planning (ACP) is defined as a person-centered, ongoing process of communication that facilitates patients' understanding, reflection, and discussion of goals, values, and preferences for future care. There is evidence for the general palliative care population that ACP increases compliance with patients' end-of-life preferences and improves quality of care near the end of life.
OBJECTIVES: To gain insight into what is known about the use and effects of ACP in palliative care for people with intellectual disabilities (IDs).
METHODS: Four databases were searched systematically: PubMed, PsycINFO, Embase, and CINAHL. A stepwise procedure was used to identify relevant studies based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement. The review included empirical quantitative, qualitative, and mixed methods studies concerning people with ID who receive palliative care or who died non-acutely, and describing ACP. Methodological quality was graded using a critical appraisal tool.
RESULTS: A total of 14 studies were included. Most studies examined the perspective of professionals and/or relatives. None of the studies focused on the perspective of patients with ID. The studies concerned different elements of ACP, mainly decision-making and organizational policies. No effect studies were found. Obstructing factors were difficulties in recognizing palliative needs and uncertainties among relatives and professionals about their roles and tasks in ACP. Conducive factors were good working relationships between professionals and relatives.
CONCLUSION: There are some indications that ACP could be useful for people with ID, but more knowledge is needed about whether and how ACP should be used.
Copyright © 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advance care planning; end-of-life decisions; intellectual disability; organizational policies; palliative care

Mesh:

Year:  2017        PMID: 28797850     DOI: 10.1016/j.jpainsymman.2017.04.016

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  5 in total

1.  Availability and effectiveness of decision aids for supporting shared decision making in patients with advanced colorectal and lung cancer: Results from a systematic review.

Authors:  Inge Spronk; Maartje C Meijers; Marianne J Heins; Anneke L Francke; Glyn Elwyn; Anne van Lindert; Sandra van Dulmen; Liesbeth M van Vliet
Journal:  Eur J Cancer Care (Engl)       Date:  2019-05-08       Impact factor: 2.328

2.  A systematic review of palliative care tools and interventions for people with severe mental illness.

Authors:  Karin den Boer; Anke J E de Veer; Linda J Schoonmade; Kim J Verhaegh; Berno van Meijel; Anneke L Francke
Journal:  BMC Psychiatry       Date:  2019-04-03       Impact factor: 3.630

3.  The palliative care needs of adults with intellectual disabilities and their access to palliative care services: A systematic review.

Authors:  Emily Adam; Katherine E Sleeman; Sarah Brearley; Katherine Hunt; Irene Tuffrey-Wijne
Journal:  Palliat Med       Date:  2020-06-17       Impact factor: 4.762

4.  Interventions for improving self-direction in people with dementia: a systematic review.

Authors:  Carola M E Döpp; Hermijntje Drenth; Paul-Jeroen Verkade; Anneke F Francke; Iris van der Heide
Journal:  BMC Geriatr       Date:  2021-03-20       Impact factor: 3.921

Review 5.  [Ethics of resuscitation and end of life decisions].

Authors:  Spyros D Mentzelopoulos; Keith Couper; Patrick Van de Voorde; Patrick Druwé; Marieke Blom; Gavin D Perkins; Ileana Lulic; Jana Djakow; Violetta Raffay; Gisela Lilja; Leo Bossaert
Journal:  Notf Rett Med       Date:  2021-06-02       Impact factor: 0.826

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.